Cited by 151T-cell and B-cell ImmunologyImmunotherapy and Immune ResponsesImmune responses and vaccinations

Reduced naïve CD 8 + T ‐cell priming efficacy in elderly adults

Open access
Briceño, Olivia, Lissina, Anna, Wanke, Kerstin, Afonso, Georgia, Braun, Amrei, Ragon, Kristanto, Miquel, Tiphaine, Gostick, Emma +7 more·2016·Aging Cell

Abstract

Aging is associated with impaired vaccine efficacy and increased susceptibility to infectious and malignant diseases. CD8(+) T-cells are key players in the immune response against pathogens and tumors. In aged mice, the dwindling naïve CD8(+) T-cell compartment is thought to compromise the induction of de novo immune responses, but no experimental evidence is yet available in humans. Here, we used an original in vitro assay based on an accelerated dendritic cell coculture system in unfractioned peripheral blood mononuclear cells to examine CD8(+) T-cell priming efficacy in human volunteers. Using this approach, we report that old individuals consistently mount quantitatively and qualitatively impaired de novo CD8(+) T-cell responses specific for a model antigen. Reduced CD8(+) T-cell priming capacity in vitro was further associated with poor primary immune responsiveness in vivo. This immune deficit likely arises as a consequence of intrinsic cellular defects and a reduction in the size of the naïve CD8(+) T-cell pool. Collectively, these findings provide new insights into the cellular immune insufficiencies that accompany human aging.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/acel.12384

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The abundance of naive T cells declines substantially with age.

    “it is well characterized that the abundance of naive T cells declines substantially with age (Briceño et al., 2016; Qi et al., 2014; Wertheimer et al., 2014).”

    From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Briceño et al., 2016

  • In older individuals, clonal expansion of Mart1-specific T cells was reduced, and these cells failed to differentiate into T-bet-expressing effector T cells.

    “In older individuals, clonal expansion of Mart1-specific T cells was reduced, and importantly, these cells failed to differentiate into T-bet-expressing effector T cells.”

    From Successful and Maladaptive T Cell Aging (2017) · cites this paper as Briceño et al., 2016

  • In vitro results on Mart1-specific T cells correlated with in vivo primary responses after tick-borne encephalitis virus vaccination, supporting in vivo relevance.

    “Most interestingly, these in vitro results correlated with in vivo primary responses after vaccination with the tick-born encephalitis virus, supporting the in vivo relevance of these in vitro findings”

    From Successful and Maladaptive T Cell Aging (2017) · cites this paper as Briceño et al., 2016

  • Naïve T cells from old people show altered TCR signaling and TCR-induced ERK phosphorylation, resulting in blunted activation.

    “Altered TCR signaling and TCR-induced ERK phosphorylation, resulting in blunted activation, have been reported in CD4+ and CD8+ naïve T cells from old people [81, 82].”
  • In an in vitro T-cell priming model, CD8+ T cells from elderly individuals consistently mounted impaired responses specific to the model neoantigen Melan-A/MART-1.

    “Using an in vitro model of T-cell priming, it was indeed shown that CD8+ T cells from elderly individuals consistently mounted impaired responses specific to a model neoantigen, such as Melan-A/MART-1 [82].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Briceño, O., Lissina, A., Wanke, K., Afonso, G., Braun, A., Ragon, K., Miquel, T., Gostick, E., Papagno, L., Stiasny, K., Price, D. A., Mallone, R., Sauce, D., Karrer, U., & Appay, V.
Affiliations
  • Inserm (FR)
  • University Hospital Zurich (CH)
  • Centre National de la Recherche Scientifique (FR)
  • Centre d'Immunologie et des Maladies Infectieuses (CIMI‐Paris) Sorbonne Universités, UPMC Univ Paris 06, DHU FAST CR7 F‐75013 Paris France
  • Institute of Infection and Immunity Cardiff University School of Medicine Cardiff Wales UK
  • Medical University of Vienna (AT)
  • Cardiff University (GB)
Corresponding author
Appay, Victor
Venue
Aging Cell
Publisher
Wiley
Published
2015-10-15
Volume
15
Issue
1
Pages
14-21
ISSN
  • 1474-9718 (ISSN-L)
  • 1474-9726
OpenAlex
W1930328534
Cited by
151
References
44
Citations by year
2026: 11 · 2025: 12 · 2024: 17 · 2023: 13 · 2022: 22 · 2021: 25 · 2020: 18 · 2019: 6 · 2018: 12 · 2017: 7 · 2016: 8
FWCI
4.44
Type
journal article
Language
en
Open access
Locations
  • Aging Cell (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Bristol Research (University of Bristol) (publishedVersion, cc-by)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
  • HAL (submittedVersion, cc-by)
  • HAL (submittedVersion)
  • Explore Bristol Research (submittedVersion, cc-by)
Funders
Swiss National Science Foundation (PP0033‐110737)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords
CD8+ T cells, naive T cell priming, immunosenescence, aging, vaccine efficacy, older adults
MeSH terms
Adult, Aged, Aged, 80 and over, Aging, Dendritic Cells, Female, Flow Cytometry, Humans, Leukocytes, Mononuclear, Lymphocyte Activation, Male, Middle Aged, CD8-Positive T-Lymphocytes, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review